DKA/HHS, DI, SIADH

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/85

encourage image

There's no tags or description

Looks like no tags are added yet.

86 Terms

1
New cards

Diabetic Ketoacidosis (DKA) Pathophysiology

Absolute lack of insulin causing severe hyperglycemia (> 250 mg/dL), lipolysis, ketone accumulation, and high anion gap metabolic acidosis

2
New cards

Hyperosmolar Hyperglycemic State (HHS) Pathophysiology

Relative lack of insulin preventing lipolysis/ketosis but causing extreme hyperglycemia (> 600 mg/dL), massive dehydration (> 9 L deficit), and hyperosmolality

3
New cards

DKA Diagnostic Blood Glucose Level

Typically greater than 250 mg/dL

4
New cards

HHS Diagnostic Blood Glucose Level

Typically greater than 600 mg/dL

5
New cards

DKA Arterial/Venous pH Target

Arterial or venous pH less than 7

6
New cards

30 (mild: 7

7
New cards

25-7

8
New cards

30, moderate: 7

9
New cards

00-7

10
New cards

24, severe: < 7

11
New cards

00)

12
New cards

DKA Serum Bicarbonate Level

Serum bicarbonate (HCO3) less than or equal to 15 mEq/L (severe: < 10 mEq/L)

13
New cards

DKA Anion Gap Threshold

Anion gap greater than 10 mEq/L, indicating high anion gap metabolic acidosis

14
New cards

HHS Diagnostic Serum Osmolality

Serum osmolality greater than 320 mOsm/kg H2O

15
New cards

DKA Primary Clinical Triad

Hyperglycemia (> 250 mg/dL), metabolic acidosis (pH < 7

16
New cards

3, HCO3 ≤ 15 mEq/L), and blood/urine ketosis

17
New cards

Gold Standard DKA Ketone Diagnostic Test

Point-of-care quantitative blood beta-hydroxybutyrate test (superior to urine ketone tests)

18
New cards

Kussmaul Respirations

Deep, rapid, labored breathing pattern in DKA compensating for metabolic acidosis by blowing off carbon dioxide

19
New cards

Fruity-Smelling Breath

Acetone odor on the breath resulting from volatile ketone accumulation in DKA

20
New cards

HHS Neurological Manifestations

Severe lethargy, stupor, and coma driven by extreme serum hyperosmolality (> 320 mOsm/kg) and cerebral dehydration

21
New cards

DKA Total Body Water Deficit

Approximately 6 liters

22
New cards

HHS Total Body Water Deficit

Exceeds 9 liters, creating severe hyperviscosity and high thromboembolic risk

23
New cards

HHS Mortality Rate vs DKA

HHS mortality is up to 20% (10 times higher than DKA) due to older age, severe dehydration, and pre-existing comorbidities

24
New cards

First Priority Intervention for DKA and HHS

Isotonic fluid resuscitation with 0

25
New cards

9% Normal Saline at 15 to 20 mL/kg/hr during the first hour to restore intravascular volume

26
New cards

Second Hour IV Fluid Selection for DKA/HHS

Guided by corrected serum sodium

27
New cards

45% Normal Saline if corrected sodium is normal or high

28
New cards

Critical Potassium Safety Rule Before Insulin

Verify serum potassium is 3

29
New cards

3 mEq/L or higher before starting IV regular insulin infusion

30
New cards

Action if Potassium is Less Than 3

31
New cards

3 mEq/L

Hold insulin infusion immediately and administer IV potassium replacement until serum K+ exceeds 3

32
New cards

3 mEq/L to prevent fatal dysrhythmias

33
New cards

Target Serum Potassium Range During Treatment

Maintain serum potassium between 4

34
New cards

0 and 5

35
New cards

0 mEq/L by adding 20 to 30 mEq K+ per liter of IV fluid when K+ is 3

36
New cards

3 to 5

37
New cards

2 mEq/L

38
New cards

Initial Continuous IV Insulin Titration Goal

Titrate IV regular insulin infusion to achieve a steady blood glucose drop of 50 to 70 mg/dL per hour

39
New cards

Critical Care Blood Glucose Target

Maintain capillary blood glucose between 140 and 180 mg/dL in critically ill clients

40
New cards

Indication to Add Dextrose to IV Fluids

Add 5% Dextrose (e

41
New cards

g

42
New cards

, D5 0

43
New cards

45% NS) when blood glucose drops below 200 mg/dL in DKA or 250 mg/dL in HHS

44
New cards

Rationale for Adding Dextrose

Prevents rapid hypoglycemia and cerebral edema while allowing continuous IV insulin to safely clear ketones and resolve acidosis

45
New cards

DKA Resolution Criteria

Blood glucose < 200 mg/dL AND at least two of the following: pH > 7

46
New cards

3, serum HCO3 ≥ 15 mEq/L, or anion gap ≤ 12 mEq/L

47
New cards

HHS Resolution Criteria

Serum osmolality < 320 mOsm/kg and recovery of baseline mental status

48
New cards

Subcutaneous Insulin Transition 2-Hour Overlap Rule

Overlap IV regular insulin with the first subcutaneous insulin injection by at least 2 hours to prevent an insulin gap and rebound DKA

49
New cards

Sodium Bicarbonate Indication in DKA

Reserved strictly for severe metabolic acidosis with pH less than 6

50
New cards

9

routine use is avoided to prevent hypokalemia and paradoxical ketosis

51
New cards

Cause of False High Initial Potassium in DKA

Insulin deficiency and metabolic acidosis shift potassium out of cells into the blood, masking total-body potassium depletion

52
New cards

Arginine Vasopressin Disorder (AVP Disorder / DI) Pathophysiology

Inability to concentrate urine due to inadequate ADH secretion (Central AVP-D) or renal tubule resistance to ADH (Nephrogenic AVP-R)

53
New cards

Central AVP Disorder (AVP-D) Etiology

Caused by posterior pituitary/hypothalamic damage from neurosurgery (20% post-op prevalence), TBI, head trauma, brain tumors, or CNS infection

54
New cards

Nephrogenic AVP Disorder (AVP-R) Etiology

Caused by renal tubule resistance to ADH, most commonly triggered by lithium toxicity, hypercalcemia, hypokalemia, or amphotericin B

55
New cards

AVP Disorder Serum Profile

Elevated serum sodium (> 145 mEq/L), elevated serum osmolality (> 300 mOsm/kg), and elevated BUN/creatinine due to severe dehydration

56
New cards

AVP Disorder Urine Profile

High urine output (> 3 L/day), low urine specific gravity (< 1

57
New cards

005), low urine osmolality (< 300 mOsm/kg), and low urinary sodium (< 40 mEq/day)

58
New cards

Hallmark Clinical Triad of AVP Disorder

Polyuria (> 3 L/day of dilute, clear urine), polydipsia (extreme thirst), and nocturia

59
New cards

Water Deprivation Test Purpose

Diagnostic gold standard that confirms AVP disorder when urine osmolality remains < 300 mOsm/kg despite fluid restriction

60
New cards

Desmopressin Challenge in Water Deprivation Test

Differentiates Central AVP-D (urine osmolality surges to > 750 mOsm/kg) from Nephrogenic AVP-R (no increase in urine osmolality)

61
New cards

Primary Hypotonic IV Fluid for AVP Disorder

Dextrose 5% in Water (D5W) or 0

62
New cards

45% Normal Saline administered at a max rate of 500 to 750 mL/hour to replace water loss

63
New cards

Safe Sodium Reduction Rate in Hypernatremia

Lower serum sodium gradually by no more than 0

64
New cards

5 mEq/L per hour to prevent rapid fluid shifts and cerebral edema

65
New cards

Desmopressin (DDAVP) Indication

First-line synthetic vasopressin analog for Central AVP-D that stimulates V2 renal receptors to reduce urine output

66
New cards

Desmopressin Medication Safety Warning

Over-retention of water causes dilutional hyponatremia and cerebral edema

67
New cards

Thiazide Diuretics Indication in Nephrogenic AVP-R

Hydrochlorothiazide paradoxically decreases urine volume by causing mild volume depletion and increasing proximal tubule reabsorption

68
New cards

Dietary Modification for AVP Disorder

A diet low in protein and low in sodium to decrease renal solute load and reduce total urine output

69
New cards

SIADH Pathophysiology

Unsuppressed release of antidiuretic hormone (ADH) forcing kidneys to reabsorb excess water, diluting blood and causing euvolemic hyponatremia

70
New cards

Most Common Malignancy Triggering SIADH

Small cell lung cancer (ectopic ADH production)

71
New cards

Common Drug Classes Causing SIADH

SSRIs (especially in adults > 65 years), chemotherapeutic agents (cisplatin), carbamazepine, and excessive desmopressin

72
New cards

SIADH Euvolemic Water Retention Characteristic

Excess water is distributed evenly across body compartments without expanding intravascular volume enough to cause hypertension, JVD, or peripheral edema

73
New cards

SIADH Serum Profile

Low serum sodium (< 135 mEq/L) and low serum osmolality (< 285 mOsm/kg H2O) indicating blood dilution

74
New cards

SIADH Urine Profile

Concentrated urine with high urine specific gravity (> 1

75
New cards

030), high urine osmolality (> 100 mOsm/kg), and high 24-hour urine sodium (> 220 mEq/day)

76
New cards

Mild-to-Moderate SIADH Serum Sodium Range

120 to 125 mEq/L presenting with nausea, anorexia, fatigue, headache, muscle cramps, and decreased urine output

77
New cards

Severe SIADH Neurological Red Flags

Serum sodium less than 120 mEq/L causing severe cerebral edema, hyporeflexia, muscle tremors, seizures, obtundation, and coma

78
New cards

SIADH Respiratory Failure Critical Threshold

Serum sodium dropping below 115 mEq/L creates an immediate risk for respiratory arrest

79
New cards

First-Line Non-Pharmacological SIADH Intervention

Strict fluid restriction to 800-1,000 mL/day to reverse dilutional hyponatremia

80
New cards

Hypertonic Saline Indication in SIADH

3% Normal Saline IV bolus (100-150 mL) via central line reserved for severe symptomatic hyponatremia (Na < 120 mEq/L)

81
New cards

Osmotic Demyelination Syndrome (ODS)

Irreversible brainstem demyelination caused by correcting hyponatremia too rapidly

82
New cards

5-1 mEq/L/hr (max 8 mEq/L in 24hr)

83
New cards

Tolvaptan (Samsca) Mechanism and Caution

Oral V2 vasopressin receptor antagonist promoting free water excretion

84
New cards

Conivaptan (Vaprisol) Administration

Continuous IV vasopressin receptor antagonist administered via central line for 2 to 4 days to promote aquaresis in hospitalized SIADH

85
New cards

Furosemide (Lasix) Role in SIADH

Loop diuretic given alongside fluid restriction/saline to increase free water excretion and lower urine osmolality

86
New cards

Seizure Precautions for SIADH

Padded side rails, functioning suction at bedside, dim room lighting, and minimized environmental stimulation for clients with Na < 120 mEq/L